Stay informed with the latest litigation news. Explore now

Csl Behring competitive analysis

Latest publications and patents of Csl Behring New

Explore the latest publications and patents granted to Csl Behring, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Csl Behring

Aug 28, 2024Pharmaceutical Product With Increased Stability Comprising ImmunoglobulinsGranted And Under Opposition
Apr 10, 2024Protein Purification And Virus Inactivation With Alkyl GlycosidesGranted And Under Opposition
Feb 21, 2024Method And System Of Protein ExtractionGranted And Under Opposition
Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific ActivityGranted And Under Opposition
Jul 22, 2020Pharmaceutical Product With Increased Stability Comprising ImmunoglobulinsGranted And Under Opposition
May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent ProteinsGranted And Under Opposition
Sep 18, 2019Immunoglobulin Preparation And Storage System For An Immunoglobulin PreparationGranted And Under Opposition
Apr 10, 2019Method For Purification Of Alpha-1-AntitrypsinRevoked
Mar 13, 2019Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation FactorGranted And Under Opposition
Dec 12, 2018Immunoglobulin PreparationGranted And Under Opposition

Explore patent oppositions filed by Csl Behring against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Method For Preparing Human Plasma ProteinsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 27, 2020
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMAMar 28, 2018
Oligopeptide-Free Cell Culture MediaBAXALTAJan 18, 2018

Explore Csl Behring's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 28, 2024Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
Apr 10, 2024Protein Purification And Virus Inactivation With Alkyl Glycosides1
Feb 21, 2024Method And System Of Protein Extraction1
Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity2
Jul 22, 2020Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent Proteins1
Sep 18, 2019Immunoglobulin Preparation And Storage System For An Immunoglobulin Preparation1
Apr 10, 2019Method For Purification Of Alpha-1-Antitrypsin1
Mar 13, 2019Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor1
Dec 12, 2018Immunoglobulin Preparation1

Latest PTAB cases involving Csl Behring New

Discover the latest PTAB cases involving Csl Behring, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Csl Behring

IPR2019-00459Dec 21, 2018CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRINGBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01313Jul 2, 2018CSL BEHRINGBIOVERATIV THERAPEUTICSInstitution Denied
IPR2017-01512May 31, 2017CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied

Top competitors of Csl Behring

Top competitors of Csl Behring based on patent oppositions.